GlassScriptPhysician profile
Gregory A Dumanian
NPI 1972533388
$49,761.41
in general payments reported to CMS, 2019-2025
29 companies · $6,608 in 2025
The $6,608 reported for 2025 was more than what 94% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,683 · 2020: $4,065 · 2021: $561 · 2022: $18K · 2023: $8,662 · 2024: $6,073 · 2025: $6,608.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Food and Beverage: $3,536 · Gift: $2,770 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,600 · Travel and Lodging: $337.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,100.00 |
| Food and Beverage | $3,536.28 |
| Gift | $2,769.98 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,600.00 |
| Travel and Lodging | $336.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Checkpoint Surgical, INC | $38,565.40 | 2019-2025 | Checkpoint Stimulators |
| Kerecis Limited | $3,187.81 | 2022-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Allergan, INC. | $3,021.39 | 2019-2022 | |
| Musculoskeletal Transplant Foundation INC. | $701.94 | 2019-2025 | |
| Acera Surgical, INC. | $654.39 | 2019-2025 | Restrata Wound Matrix |
| Axogen | $575.00 | 2020-2024 | Avance Nerve Graft, Axoguard Nerve Protector, Axoguard Ha+ Nerve Protector |
| Tepha INC | $394.46 | 2019 | |
| Polynovo North America LLC | $393.21 | 2022-2024 | Novosorb Btm |
| Mentor Worldwide LLC | $354.15 | 2019-2023 | Mentor Memorygel Resterilizable Gel Sizer |
| Davol INC. | $320.21 | 2025 | Arista, Surgiphor |
| Convatec INC. | $179.02 | 2025 | |
| Rti Surgical, INC | $149.59 | 2025 | |
| Ets Wound Care LLC | $142.23 | 2025 | Mirragen Advanced Wound Matrix |
| Integra Lifesciences Corporation | $141.90 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Avita Medical Americas, LLC | $141.09 | 2025 | Recell, Permeaderm, Cohealyx |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acelrx Pharmaceuticals, INC. | $122.66 | 2020 | |
| Medline Industries LP | $121.64 | 2019 | |
| Depuy Synthes Sales INC. | $120.15 | 2025 | Trumatch |
| Vioptix INC | $110.86 | 2025 | |
| Abbvie INC. | $110.50 | 2024 | |
| Ethicon US, LLC | $71.60 | 2023 | Dermabond Prineo, Stratafix |
| Tela Bio, INC. | $43.37 | 2022-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Urgo Medical North America, LLC | $42.65 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Innovation Technologies INC | $27.00 | 2019 | |
| Bard Peripheral Vascular, INC. | $22.40 | 2021 | |
| Galderma Laboratories, L.P. | $17.42 | 2021 | |
| Coopersurgical, INC. | $15.68 | 2024 | Fisherbrand Disposable Liquid Infant Heel Warmer |
| Sientra, INC. | $13.69 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$32,508,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Dumanian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.